TrialTrials2021

Resource and infrastructure challenges on the RESIST-2 Trial: an implementation study of drug resistance genotype-based algorithmic ART switches in HIV-2-infected adults in Senegal.

Dana N Raugi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.